July 2nd, 2007 U.S.A. BSP, an Israeli ground-breaking start-up company developing and marketing innovative, simple and cost effective systems for early stage non-invasive diagnosis and monitoring of ischemic heart disease through biological signal processing, announced that it has received US notification of issuance for a second patent which reinforces its original technology. BSP´s flagship product, the HyperQTM Stress System, enables early stage non-invasive diagnosis and monitoring of ischemic heart disease in large populations by analysis and processing of ECG signals.
